(1) REPORTS OF MEDICAL EVENTS.
(a) A licensee shall report to the department
any event, except for events that result from intervention by a patient or
human research subject, in which the administration of radioactive material or
resulting radiation, except for permanent implant brachytherapy, results in any
of the following:
1. A dose that differs from
the prescribed dose or dose that would have resulted from the prescribed dosage
by more than 0.05 Sv (5 rem) effective dose equivalent, 0.5 Sv (50 rem) to an
organ or tissue or 0.5 Sv (50 rem) shallow dose equivalent to the skin and to
which any of the following apply:
a. The total
dose delivered differs from the prescribed dose by 20% or more.
b. The total dosage delivered differs from
the prescribed dosage by 20% or more or falls outside the prescribed dosage
range.
c. The fractionated dose
delivered differs from the prescribed dose, for a single fraction, by 50% or
more.
2. A dose that
exceeds 0.05 Sv (5 rem) effective dose equivalent, 0.5 Sv (50 rem) to an organ
or tissue or 0.5 Sv (50 rem) shallow dose equivalent to the skin from any of
the following:
a. An administration of a wrong
pharmaceutical.
b. An
administration of a radioactive drug containing radioactive material by the
wrong route of administration.
c.
An administration of a dose or dosage to the wrong patient or human research
subject.
d. An administration of a
dose delivered by the wrong mode of treatment.
e. A leaking sealed source.
3. A dose to the skin or an organ
or tissue other than the treatment site that exceeds by 0.5 Sv (50 rem) to an
organ or tissue and 50% or more of the dose expected from the administration
defined in the written directive.
(am) For permanent implant brachytherapy, a
licensee shall report to the department any event, except for events that
result from intervention by a patient or human research subject, in which the
administration of byproduct material or radiation from byproduct material,
excluding sources that were implanted in the correct site but migrated outside
the treatment site, results in any of the following:
1. The total source strength administered
that differs by 20% or more from the total source strength documented in the
post-implantation portion of the written directive.
2. The total source strength administered
outside of the treatment site exceeding 20% of the total source strength
documented in the post-implantation portion of the written directive.
3. Administration of the wrong
radionuclide.
4. Administration to
the wrong individual or human research subject.
5. Sealed source implanted directly into a
location discontiguous from the treatment site, as documented in the
post-implantation portion of the written directive.
6. A leaking sealed source resulting in a
dose that exceeds 0.5 Sv (50 rem) to an organ or tissue.
(b) A licensee shall report to the department
any event resulting from intervention of a patient or human research subject in
which the administration of radioactive material or radiation therefrom results
or will result in an unintended permanent functional damage to an organ or a
physiological system, as determined by a physician.
(c) A licensee shall notify the department by
telephone no later than the next calendar day after discovery of the medical
event.
Note: Submit report to the Department via
telephone at (608) 267-4797 or via facsimile at (608) 267-3695.
(d)
1. A
licensee shall submit a written report to the department within 15 working days
after discovery of the medical event.
2. The written report required in subd. 1.
shall include all the following:
a. The
licensee's name.
b. The name of the
prescribing physician.
c. A brief
description of the event.
d. Why
the event occurred.
e. Any effect
on the person who received the administration.
f. Any actions that have been taken or are
planned to prevent recurrence.
g.
Whether the licensee notified the person or the person's responsible relative
or guardian and if not, why not.
h.
If there was notification, what information was provided.
3. The report required in subd. 1. may not
contain the affected individual's name or any other information that could lead
to identification of the person.
Note: Submit written reports to the Department
at: Department of Health Services, Radiation Protection Section, P.O. Box 2659,
Madison WI 53701-2659.
(e) A licensee shall notify the referring
physician of the event and also notify the person who is the subject of the
medical event no later than 24 hours after its discovery unless the referring
physician personally informs the licensee either that the physician will inform
the person or that, based on medical judgement, telling the person would be
harmful. A licensee is not required to notify the person without first
consulting the referring physician. If the referring physician or the affected
person cannot be reached within 24 hours, a licensee shall notify the person as
soon as possible thereafter. A licensee may not delay any appropriate medical
care for the person, including any necessary remedial care resulting from the
medical event, because of any delay in notification. To meet the requirements
of this paragraph, the notification of the person who is the subject of the
medical event may be made instead to that person's responsible relative or
guardian. If a verbal notification is made, a licensee shall inform the person
or appropriate responsible relative or guardian that a written description of
the event may be obtained from the licensee upon request. A licensee shall
provide the written description if requested.
(f) If the person who is the subject of the
medical event was notified under par. (d), a licensee shall also furnish within
30 days after discovery of the medical event a written report to the person by
sending either of the following:
1. A copy of
the report that was submitted to the department.
2. A brief description of both the event and
the consequences as they may affect the person.
(g) Aside from the notification requirement,
nothing in this subsection affects any rights or duties of a licensee or
physician in relation to each other, to any person affected by the medical
event or to any individual's responsible relatives or guardians.
(h) A licensee shall retain a record of a
medical event under s.
DHS 157.71 (4). A copy of the record required under s.
DHS 157.71 (4) shall be provided to the referring physician, if other than the
licensee, no later then 15 days after the discovery of the
event.
(2) REPORT OF A
DOSE TO AN EMBRYO OR FETUS OR A NURSING CHILD.
(a) A licensee shall report to the department
any dose to an embryo or fetus that is greater than 50 mSv (5 rem) dose
equivalent that is a result of an administration of radioactive material or
radiation from radioactive material to a pregnant individual unless the dose to
the embryo or fetus was specifically approved, in advance, by the authorized
user.
(b) A licensee shall report
to the department any dose to a nursing child that is a result of an
administration of radioactive material to a breast-feeding individual that
meets either of the following criteria:
1.
Greater than 50 mSv (5 rem) total effective dose equivalent.
2. Resulted in unintended permanent
functional damage to an organ or a physiological system of the child, as
determined by a physician.
(c) A licensee shall notify the department by
telephone no later than the next calendar day after discovery of a dose to the
embryo, fetus or nursing child that requires a report in par. (a) or
(b).
(d) A licensee shall submit a
written report to the department within 15 days after discovery of a dose to
the embryo, fetus or nursing child that requires a report in par. (a) or (b).
The written report shall include all of the following information:
1. The licensee's name.
2. The name of the prescribing
physician.
3. A brief description
of the event.
4. Why the event
occurred.
5. The effect, if any, on
the embryo, fetus or the nursing child.
6. What actions, if any, have been taken or
are planned to prevent recurrence.
7. Certification that the licensee notified
the pregnant individual or mother or the mother's or child's responsible
relative or guardian, and if not, why not.
8. The report may not contain the
individual's or child's name or any other information that could lead to
identification of the individual or child.
(e) A licensee shall provide notification of
the event to the referring physician and also notify the pregnant individual or
mother, both hereafter referred to as the mother, no later than 24 hours after
discovery of an event that would require reporting under par. (a) or (b),
unless the referring physician personally informs the licensee either that he
or she will inform the mother or that, based on medical judgment, telling the
mother would be harmful. A licensee is not required to notify the mother
without first consulting with the referring physician. If the referring
physician or mother cannot be reached within 24 hours, a licensee shall make
the appropriate notifications as soon as possible thereafter. A licensee may
not delay any appropriate medical care for the embryo, fetus or nursing child,
including any necessary remedial care as a result of the event, because of any
delay in notification. To meet the requirements of this paragraph, the
notification may be made to the mother's or child's responsible relative or
guardian instead of the mother. If a verbal notification is made, the licensee
shall inform the mother, or the mother's or child's responsible relative or
guardian, that a written description of the event can be obtained from the
licensee upon request. A licensee shall provide such a written description if
requested.
(f) A licensee shall do
all the following:
1. Annotate a copy of the
report provided to the department with all of the following information:
a. Name of the pregnant individual or the
nursing child who is the subject of the event.
b. Identification number or if no other
identification number is available, the social security number of the pregnant
individual or the nursing child who is the subject of the
event.
2. Provide a copy
of the annotated report to the referring physician, if other than the licensee,
no later than 15 days after the discovery of the event.
(g) A licensee shall retain a record of a
dose to an embryo, fetus or a nursing child under s.
DHS 157.71 (5).
(3) REPORTS OF
LEAKING SOURCES. A licensee shall submit a written report to the department
within 5 working days if a leakage test required by s.
DHS 157.62 (5) reveals
the presence of 185 Bq (0.005 µCi) or more of removable contamination.
The written report shall include the model number and serial number, if
assigned, of the leaking source, the radionuclide and its estimated activity,
the results of the test, the date of the test and the action taken.
(4) REPORTS FOR AN ELUATE EXCEEDING
PERMISSIBLE MOLYBDENUM-99, STRONTIUM-82, AND STRONTIUM-85 CONCENTRATION.
(a) The licensee shall notify by telephone
the department and the distributor of the generator within 7 calendar days
after discovery that an eluate exceeded the permissible concentration listed in
s.
DHS 157.63 (3) (a) at the time of generator elution. The telephone report to
the department must include all of the following information:
1. The manufacturer, model number, and serial
or lot number of the generator.
2.
The results of the measurement and the date of the measurement.
3. Whether dosages were administered to
patients or human research subjects.
4. When the distributor was
notified.
5. The action taken in
response.
Note: A report may be submitted to the
department via telephone at (608) 267-4797.
(b) A licensee who makes a report required by
par. (a) shall submit a written report within 30 days of the initial telephone
report containing all of the following information:
1. The action taken by the
licensee.
2. The patient dose
assessment.
3. The methodology used
to make the dose assessment if the eluate was administered to patients or human
research subjects.
4. The probable
cause and an assessment of failure in the licensee's equipment, procedures or
training that contributed to the excessive readings if an error occurred in the
licensee's breakthrough determination.
5. The information in the telephone report as
required by par. (a).